Close Menu
Home » Business & Policy » Genetics & Genomics Reimbursement

Genetics & Genomics Reimbursement

News and trends on diagnostics testing, insurance coverage, and reimbursement.

Anthem Blue Cross Brings CareDx's AlloMap Heart Transplant Test In Network

The diagnostic will now be a contracted service with Anthem Blue Cross of California and 10 of its affiliated health plans.

CMS Reopens National Coverage Determination for NGS Testing in Advanced Cancer

The government payor asked the public to specifically weigh in on the evidence supporting germline testing to assess treatment benefit for patients with hereditary cancer syndromes.

Local Coverage Determinations Roundup: Guardant Health, Natera, Transplant Genomics, and More

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

Local Coverage Determinations Roundup: Natera, Veracyte, and Decipher

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

NantHealth Slows Cash Burn While Still Trying to Solve 'Reimbursement Conundrum'

Premium

NantHealth CEO Patrick Soon-Shiong said that the company is seeking a fast-track FDA clearance predicated on Memorial Sloan Kettering's 468-gene panel.

Mar 29, 2019

Local Coverage Determinations Roundup: Transplant Genomics, DermTech, GenomeDx, and More

Mar 28, 2019

Palmetto Issues Draft Local Coverage Determination for Natera Kidney Transplant Test

Mar 28, 2019

Guardant Health Liquid Biopsy Test Gets Draft LCD for Most Advanced Solid Tumors

Mar 27, 2019

CMS to Revisit National Coverage Determination on NGS Tumor Testing

Mar 22, 2019

Confirmatory Testing, Insurance Coverage Growing Alongside DTC Genetic Testing

Premium
Mar 14, 2019

Myriad Genetics Melanoma Test Gets Final LCD

Mar 08, 2019

CMS Acknowledges Stakeholder Concerns Over Decision Not to Cover Germline NGS in Early Cancer Patients

Mar 05, 2019

Biotheranostics Breast Cancer Test Receives Expanded Medicare Coverage Determination

Mar 04, 2019

Veracyte Envisia Genomic Classifier Gets Medicare Coverage to Aid in Lung Disease Dx

Feb 01, 2019

Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests

Jan 22, 2019

Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk

Premium
Jan 07, 2019

Myriad Pushing Ahead With Payors on GeneSight as Data From Large Randomized Study is Published

Jan 04, 2019

Pathologist Group Asks Medicare to Reconsider Payment for BRCA Genetic Testing CPT Codes

Dec 26, 2018

Personalized Medicine 2018: More Drugs, Greater NGS Adoption, Growing Appreciation of Dx Value

Premium
Dec 19, 2018

Breast Cancer Molecular Tests Included in Recommendations by UK's NICE

Dec 07, 2018

Study Adds to Evidence for Genelex PGx Testing But Proving Value Remains Difficult, Authors Say

Premium

The Scan

Harder to Breathe

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

Sequence From the Jomon Period

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Shifting Sands of Gene Variant Interpretation

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

This Week in Science

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.